Literature DB >> 6587955

Defective splenic reticuloendothelial function in idiopathic membranous nephropathy.

E McGinley, W Martin, N Henderson, J M Boulton-Jones.   

Abstract

We studied splenic macrophage reticuloendothelial function in 18 patients with idiopathic membranous nephropathy and eight patients with mesangio-capillary glomerulonephritis by measuring the clearance from the circulation of technetium labelled, autologous, antibody coated erythrocytes (IgG cells) or heat damaged erythrocytes (HDE). Nine of 15 rhesus-D positive patients with membranous nephropathy had delayed clearance of the IgG cells and the defect did not correlate with disease activity. Circulating immune complexes were not detected in any of the patients with membranous nephropathy. The defect in clearance of the IgG cells in the membranous patients was associated with the presence of HLA-B8 and DR3. In the mesangio-capillary glomerulonephritis patients, the clearance rates of the IgG cells were fast-normal in six and enhanced in two, and correlated with the clearance of HDE. The clearance rates of the cells in this group correlated with the degree of hypocomplementaemia but not with the disease activity nor HLA haplotype.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6587955      PMCID: PMC1536211     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

Review 1.  NIH conference. Pathophysiology of immune hemolytic anemia.

Authors: 
Journal:  Ann Intern Med       Date:  1977-08       Impact factor: 25.391

Review 2.  Immune complex disease in experimental animals and man.

Authors:  C G Cochrane; D Koffler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

Review 3.  Histocompatibility-linked immune response genes.

Authors:  B Benacerraf; H O McDevitt
Journal:  Science       Date:  1972-01-21       Impact factor: 47.728

Review 4.  Diagnosis of immunopathologic renal disease.

Authors:  C B Wilson; F J Dixon
Journal:  Kidney Int       Date:  1974-06       Impact factor: 10.612

5.  Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G.

Authors:  H Huber; M J Polley; W D Linscott; H H Fudenberg; H J Müller-Eberhard
Journal:  Science       Date:  1968-12-13       Impact factor: 47.728

6.  Saturation of the reticuloendothelial system with soluble immune complexes.

Authors:  A O Haakenstad; M Mannik
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

7.  Significance of complement-positive Coombs test in patients with glomerular disease.

Authors:  O Kourilsky; C Poyau-Lemaux; J P Lucas; G Neuilly; G Richet
Journal:  Lancet       Date:  1974-09-21       Impact factor: 79.321

8.  Red cells coated with immunoglobulin G: binding and sphering by mononuclear cells in man.

Authors:  A F LoBuglio; R S Cotran; J H Jandl
Journal:  Science       Date:  1967-12-22       Impact factor: 47.728

9.  Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis.

Authors:  C M Lockwood; A J Pinching; P Sweny; A J Rees; B Pussell; J Uff; D K Peters
Journal:  Lancet       Date:  1977-01-08       Impact factor: 79.321

10.  Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG).

Authors:  B Mantovani; M Rabinovitch; V Nussenzweig
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  2 in total

1.  A transient monocyte defective function in idiopathic nephrotic syndrome (lipoid nephrosis).

Authors:  A Branellec; J Laurent; J M Heslan; C Bruneau; G Lagrue
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

2.  Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees.

Authors:  S Lobatto; M R Daha; A A Voetman; J H Evers-Schouten; A A Van Es; E K Pauwels; L A Van Es
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.